| 产品编号 | bs-0866R |
| 英文名称 | HHV4/CMV Rabbit pAb |
| 中文名称 | 人类巨细胞病毒抗体 |
| 别 名 | EB2_EBVB9; mRNA export factor EB2; Mta; ORF57 protein homolog; Protein SM; BSLF2; BMLF1; ORF57; HHV4tp2_gp21HHV4; EBV; Human herpesvirus 4 type 2. |
| 研究领域 | 免疫学 细菌及病毒 |
| 抗体来源 | Rabbit |
| 克隆类型 | Polyclonal |
| 克 隆 号 | |
| 产品应用 | WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复）
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理论分子量 | 53 kDa |
| 检测分子量 | |
| 性 状 | Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from HHV4 2: 201-300/479 |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 缓 冲 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存条件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 产品介绍 |
ORF57 herpesvirus core gene UL54 family. No data available. Function: Promotes the nuclear export of a subset of early and late viral mRNAs by interacting with mRNAs and cellular export proteins. Additionally may prevent the establishment of cellular antiviral state, by acting as an alternative splicing factor for cellular RNAs such as STAT1, resulting in a STAT1 mRNA incapable of producing the STAT1alpha isoform. Subunit: Interacts with host XPO1 and with the XPO1 export pathway components small GTPase RAN and nucleoporin NUP214. Interacts with host SPEN, OTT1 and OTT3. Subcellular Location: Host nucleus. Host cytoplasm. Note=shuttles between the nucleus and the cytoplasm. Post-translational modifications: Phosphorylated by cellular protein kinase CK2. Similarity: Belongs to the HHV-1 ICP27 protein family. Database links: SwissProt: Q04360 Epstein-Barr virus |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
